Today, November 12, Shareholder Sarah Churchill Llamas moderated the panel discussion “Successful Raises and Investor Considerations” at the Texas Life Science Venture Forum, hosted by Rice Alliance for Technology and Entrepreneurship and BioHouston. The panel discussed advice for entrepreneurs/inventors that impacts valuation; the specific risks that erode valuation and how companies can mitigate risks at various stages of growth; and approaches to increase a company’s valuation once you are invested or engaged.
The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. The event represents an opportunity to meet investors, learn about promising life science companies, to learn about opportunities for entrepreneurs, investment professionals, big pharma, academics and business executives serving the life science industry.
Panelists:
- Mark Chandler, Managing Director, Upstream Partners
- Aaron G.L. Fletcher, PhD, Managing Partner & Co-Founder, Bios Partners
- Jack Henneman, Director, Alafair Biosciences